Juno Diagnostics is developing genetic testing solutions to improve access to vital health information. The company's lead product is an NIPT solution that simplifies sample collection and improves access to high quality genetic testing results without the high cost, long lead times, and phlebotomy requirements of traditional NIPT.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/12/21 | $25,000,000 | Series A |
Perceptive Advisors | undisclosed |
